ANI Pharmaceuticals Inc
General ticker "ANIP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.1B
ANI Pharmaceuticals Inc follows the US Stock Market performance with the rate: 6.2%.
Estimated limits based on current volatility of 1.7%: low 52.73$, high 54.59$
Factors to consider:
- US accounted for 99.9% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [41.27$, 66.26$]
- 2024-12-30 to 2025-12-30 estimated range: [43.84$, 69.79$]
Financial Metrics affecting the ANIP estimates:
- Positive: Non-GAAP EPS, $ of 4.72 > 2.29
- Positive: Operating cash flow per share per price, % of 12.88 > 12.76
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.03
- Positive: 9.05 < Operating profit margin, % of 9.65
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
Short-term ANIP quotes
Long-term ANIP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $207.39MM | $316.38MM | $486.82MM |
| Operating Expenses | $247.18MM | $351.67MM | $439.85MM |
| Operating Income | $-39.79MM | $-35.28MM | $46.97MM |
| Non-Operating Income | $-16.27MM | $-27.38MM | $-27.10MM |
| Interest Expense | $11.92MM | $28.05MM | $26.94MM |
| R&D Expense | $11.37MM | $22.32MM | $34.29MM |
| Income(Loss) | $-56.06MM | $-62.66MM | $19.87MM |
| Taxes | $-13.46MM | $-14.77MM | $1.09MM |
| Profit(Loss) | $-42.60MM | $-47.90MM | $18.78MM |
| Stockholders Equity | $333.89MM | $313.69MM | $432.75MM |
| Inventory | $81.69MM | $105.36MM | $111.20MM |
| Assets | $771.60MM | $760.09MM | $904.42MM |
| Operating Cash Flow | $3.32MM | $-31.20MM | $118.96MM |
| Capital expenditure | $23.64MM | $16.45MM | $18.51MM |
| Investing Cash Flow | $-105.48MM | $-15.74MM | $-18.51MM |
| Financing Cash Flow | $194.59MM | $-5.13MM | $67.44MM |
| Earnings Per Share* | $-3.38 | $-2.95 | $0.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.